The risk factors for in-stent restenosis following drug-eluting stent implantation in end-stage renal disease patients receiving renal replacement therapy

Back

ESC Premium Access

The risk factors for in-stent restenosis following drug-eluting stent implantation in end-stage renal disease patients receiving renal replacement therapy

Session: The association of diabetes and renal disease with poor percutaneous coronary intervention outcomes

Topic: Restenosis

Speaker: Mr T. Issarawattana (Nakhon Si Thammarat, TH)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Mr Thanaphruet Issarawattana

Maharaj Nakhon Si Thammarat Hospital, Nakhon Si Thammarat (Thailand)

0 follower

5 more presentations in this session

Influence of acute kidney injury and chronic kidney disease on 3-year clinical outcomes in patients with AMI treated by contemporary PCI and optimal medical therapy; insights from J-MINUET study

Speaker: Professor Y. Ozaki (Aichi, JP)

A simplified bedside model for acute kidney injury prediction after percutaneous coronary intervention

Speaker: Assistant Professor D. Balanescu (Rochester, US)

Comparison of clinical outcomes in diabetic and non-diabetic patients undergoing coronary bifurcation stenting

Speaker: Assistant Professor S. Lim (Seoul, KR)

Long-term outcome of diabetic patients after unprotected left main percutaneous coronary interventions

Speaker: Doctor O. Nemeth (Budapest, HU)

Comparative clinical outcomes of amphilimus-eluting stents in diabetic versus non-diabetic patients

Speaker: Assistant Professor J. Kim (Seoul, KR)

Access the full session

The association of diabetes and renal disease with poor percutaneous coronary intervention outcomes

Speakers: Mr T. Issarawattana, Professor Y. Ozaki, Assistant Professor D. Balanescu, Assistant Professor S. Lim, Doctor O. Nemeth...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources